+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing with China: China - Infectious Disease Most Recent 50

  • ID: 5187928
  • Report
  • October 2020
  • Region: Global, China
  • 90 pages
  • Life Science Licensing
This trends report provides a comprehensive analysis on the most recent 50 licensing deals and negotiations reported for the healthcare companies of China in the Infectious Disease medicine group during January 1, 2019 to September 30, 2020, categorized and summarized by various important aspects such as healthcare sub-sectors, market capitalization groups, across key regions, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segments of China for the Infectious Disease medicine group. The report is extremely useful for the healthcare company executives negotiating licensing deals, as well as for the investors analyzing varied kinds of transaction options for licensing deals in China in the Infectious Disease medicine group. The report provides comprehensive information with twenty one months’ healthcare licensing transactions analyzed at one place and small, medium and big multinational/non-multinational companies covered. The licensing trends and directions are summarized here after an in-depth analysis based on the comprehensive news gathering followed by insightful research.
Note: Product cover images may vary from those shown
Introduction

Research Design

Chapter 1: Analysis of most recent 50 healthcare inventions of China in the Infectious Disease medicine group licensed during last twenty one months
1.1 Healthcare sub-sectors with most licensing deals
1.2 Market capitalization groups with most licensing deals
1.3 Licensing payment arrangements most followed
1.4 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of most recent 50 licensing deals of China in the Infectious Disease medicine group by key attributes during last twenty one months
2.1 For each of the healthcare sub-sectors
2.2 For each of the marketcap groups
2.3 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Most recent 50 healthcare inventions licensed for China in the Infectious Disease medicine group during last twenty one months - By company name
Appendix 2 List of companies/institutes covered - By company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By market capitalization group and company name
Appendix 5 List of non-listed companies covered - By company name
Appendix 6 List of not-for-profit groups covered - By institute name
Appendix 7 List of companies/institutes covered - By terms of payment and company name
Appendix 8 Licensing deals discontinued for China in the Infectious Disease medicine group during last twenty one months
Note: Product cover images may vary from those shown

Loading
LOADING...

Loading
LOADING...

Adroll
adroll